Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

PDX Models

Patient-derived xenograft (PDX) models from the Mouse Biology Program – powerful tools in cancer research and personalized treatment strategies.


The Mouse Biology Program specializes in rapidly creating patient-derived xenograft (PDX) models using freshly harvested and frozen tumors. These tumors can be implanted heterotopically, subcutaneously, or orthotopically under the renal capsule into highly immunodeficient mouse strains (e.g., NSG, NRG) or immuno-humanized mice. These PDX models provide a highly relevant platform for studying human cancers in a living system, allowing researchers to investigate tumor growth, metastasis, and therapeutic responses in a controlled, reproducible environment.

Once the PDX models are established, we offer a wide range of additional services to support ongoing research, including:

  • Serial Passage: We can pass tumors through multiple generations to maintain the model and ensure consistent tumor biology.
  • Drug Testing: We perform in vivo drug efficacy studies to evaluate potential therapies, offering insights into tumor response, resistance mechanisms, and therapeutic windows.
  • Tumor Harvest: Once the tumor has reached a desired size, we can harvest it for further analysis.
  • Histopathology: Detailed histopathological examination of the harvested tumor is available to assess morphological characteristics and confirm tumor identity.
  • Genetic and Immune Profiling: We provide genetic and immune profiling services to characterize both the tumor and host response, offering insights into mutations, gene expression, and immune interactions within the tumor microenvironment.

By combining our expertise in creating PDX models with these comprehensive services, we help advance cancer research and therapy development by providing robust, clinically relevant models tailored to your study needs.